Skip to main content
Primo Nutraceuticals Inc. logo

Primo Nutraceuticals Inc. — Investor Relations & Filings

Ticker · BUGVF ISIN · CA74167D2041 CSE Real estate activities
Open in API
Filings indexed 201 across all filing types
Latest filing 2021-11-19 Regulatory Filings
Country CA Canada
Listing CSE BUGVF

About Primo Nutraceuticals Inc.

https://www.primonutraceuticals.com

Primo Nutraceuticals Inc. is an investment and real estate development company dedicated to the cannabis cultivation sector. The company provides strategic capital and funding to support the growth in the production, processing, retail, and branding of cannabis and non-cannabis related products. Core operations include the ownership and development of commercial real estate properties, offering built-out turnkey solutions tailored for cannabis cultivation facilities. Furthermore, Primo Nutraceuticals is engaged in medicinal and botanical manufacturing, and the direct production, processing, and branding of cannabis and related goods.

Recent filings

Filing Released Lang Actions
Letter from successor auditor.pdf
Regulatory Filings Classification · 95% confidence The document is a letter addressed to securities commissions regarding a change of auditor notice for Primo Nutraceuticals Inc. It references compliance with National Instrument 51-102, which governs continuous disclosure obligations in Canada. The letter confirms agreement with statements in the auditor change notice. The document is short (844 characters) and serves as a certification or confirmation related to an auditor change, not a full audit report or annual report. It does not contain financial statements or substantive financial data. Therefore, it fits best under Regulatory Filings (RNS) as an officer certification or attestation related to regulatory compliance.
2021-11-19 English
Letter from former auditor.pdf
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the British Columbia Securities Commission regarding a Change of Auditor Notice pursuant to National Instrument 51-102. It references a prior Change of Auditor Notice dated June 17, 2021, and confirms agreement with the information contained therein. The document is short (819 characters) and does not contain any financial statements or detailed audit results. It is essentially a confirmation letter related to an auditor change, which fits best under Regulatory Filings (RNS) as it is a compliance-related notice rather than a full audit report or annual report.
2021-11-19 English
Notice.pdf
Regulatory Filings Classification · 95% confidence The document is a formal notice regarding a change of auditor, referencing Section 4.11 of National Instrument 51-102, which governs continuous disclosure obligations for Canadian issuers. It details the resignation of the previous auditor and appointment of a new auditor, with no reservations or reportable events noted. The document is short (1453 characters) and serves as an official announcement rather than a full audit report or annual report. This fits the category of Regulatory Filings (RNS), which includes compliance documents and notices that do not constitute full reports themselves.
2021-11-19 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a corporate update from Primo Nutraceuticals Inc. It discusses the status of a cease trade order due to delayed financial statement filing and ongoing audit processes. It also announces a dividend distribution of shares in an associated company, Marianna Naturals Corp., to Primo shareholders. The document does not contain actual financial statements or detailed financial data but rather provides an update on regulatory and corporate matters, including audit delays and shareholder dividend information. The length is under 5,000 characters and the content is more of an announcement/update rather than a full financial report or detailed management discussion. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and corporate update that does not fit into more specific categories like Annual Report, Interim Report, or Earnings Release.
2021-04-14 English
Material change report - English.pdf
M&A Activity Classification · 95% confidence The document is a 51-102F3 Material Change Report filed by Primo Nutraceuticals Inc. It announces a binding Letter of Intent (LOI) to acquire 100% of the assets of Full Spectrum Biosciences Inc. The content focuses on the terms of the transaction, the assets involved, and the strategic rationale behind the acquisition. There is no detailed financial data or comprehensive financial statements included, nor is it a full annual or quarterly report. The document is not a regulatory certification or officer attestation. It is clearly an announcement of a material corporate transaction involving acquisition of assets, which fits the definition of M&A Activity filings. Therefore, the appropriate classification is M&A Activity (TAR). The document length (over 10,000 characters) and detailed transaction description support this classification with high confidence.
2020-11-12 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing that Primo Nutraceuticals Inc. has entered into a binding Letter of Intent (LOI) to acquire 100% of the assets of Full Spectrum Biosciences Inc. It details the terms of the transaction, the assets involved, and includes forward-looking statements. There is no indication that this is a full financial report, audit, or regulatory filing. The content focuses on the acquisition announcement and transaction terms, which aligns with M&A activity. The document is not a merger proxy statement or tender offer form but an announcement of a merger-related transaction. Therefore, the appropriate classification is M&A Activity (TAR). The document length (7628 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2020-11-12 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.